Chrome Extension
WeChat Mini Program
Use on ChatGLM

Maintenance Durvalumab after First-Line Chemotherapy in Patients with HER2-negative Advanced Oesophago-Gastric Adenocarcinoma: Results from the Randomised PLATFORM Study

C. Fong, B. Patel,C. Peckitt, E. Bourmpaki,L. Satchwell, S. Cromarty, S. Kidd,K. von Loga,M. Uhlik,R. Begum, T. Rana,T. Waddell,S. Darby, A. Bradshaw,T. Roques, C. Morgan, C. Rees,R. Herbertson,P. Das, C. Thompson,M. Hewish,R. Petty,F. Thistlethwaite,S. Rao,N. Starling,I. Chau,D. Cunningham

ESMO Open(2024)

Cited 0|Views2
Key words
durvalumab,checkpoint inhibitor,oesophageal adenocarcinoma,gastric cancer,maintenance therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined